Pseudoxanthoma elasticum medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 21: Line 21:
*Pentoxifylline - This drug alters erythrocyte rheology, thus, reducing the blood viscosity.  This drug should be used with caution due to its ability to cause hemorrhage.
*Pentoxifylline - This drug alters erythrocyte rheology, thus, reducing the blood viscosity.  This drug should be used with caution due to its ability to cause hemorrhage.
*Cessation of tobacco - Tobacco worsens the outcome of this condition.
*Cessation of tobacco - Tobacco worsens the outcome of this condition.
===Cutaneous complications===
* Collagen and autologous fat injections have been used for the treatment of mental creases.<ref name="Galadari-2003">{{Cite journal  | last1 = Galadari | first1 = H. | last2 = Lebwohl | first2 = M. | title = Pseudoxanthoma elasticum: Temporary treatment of chin folds and lines with injectable collagen. | journal = J Am Acad Dermatol | volume = 49 | issue = 5 Suppl | pages = S265-6 | month = Nov | year = 2003 | doi = 10.1016/S0190 | PMID = 14576648 }}</ref>


==References==
==References==

Revision as of 20:44, 19 August 2013

Pseudoxanthoma elasticum Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Pseudoxanthoma elasticum medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudoxanthoma elasticum medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

Guidance

FDA on Pseudoxanthoma elasticum medical therapy

on Pseudoxanthoma elasticum medical therapy

Pseudoxanthoma elasticum medical therapy in the news

Blogs on Pseudoxanthoma elasticum medical therapy

Directions to Hospitals Treating Pseudoxanthoma elasticum

Risk calculators and risk factors for Pseudoxanthoma elasticum medical therapy

WikiDoc Resources for Pseudoxanthoma elasticum medical therapy

Articles

Most recent articles on Pseudoxanthoma elasticum medical therapy

Most cited articles on Pseudoxanthoma elasticum medical therapy

Review articles on Pseudoxanthoma elasticum medical therapy

Articles on Pseudoxanthoma elasticum medical therapy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pseudoxanthoma elasticum medical therapy

Images of Pseudoxanthoma elasticum medical therapy

Photos of Pseudoxanthoma elasticum medical therapy

Podcasts & MP3s on Pseudoxanthoma elasticum medical therapy

Videos on Pseudoxanthoma elasticum medical therapy

Evidence Based Medicine

Cochrane Collaboration on Pseudoxanthoma elasticum medical therapy

Bandolier on Pseudoxanthoma elasticum medical therapy

TRIP on Pseudoxanthoma elasticum medical therapy

Clinical Trials

Ongoing Trials on Pseudoxanthoma elasticum medical therapy at Clinical Trials.gov

Trial results on Pseudoxanthoma elasticum medical therapy

Clinical Trials on Pseudoxanthoma elasticum medical therapy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pseudoxanthoma elasticum medical therapy

NICE Guidance on Pseudoxanthoma elasticum medical therapy

NHS PRODIGY Guidance

FDA on Pseudoxanthoma elasticum medical therapy

CDC on Pseudoxanthoma elasticum medical therapy

Books

Books on Pseudoxanthoma elasticum medical therapy

News

Pseudoxanthoma elasticum medical therapy in the news

Be alerted to news on Pseudoxanthoma elasticum medical therapy

News trends on Pseudoxanthoma elasticum medical therapy

Commentary

Blogs on Pseudoxanthoma elasticum medical therapy

Definitions

Definitions of Pseudoxanthoma elasticum medical therapy

Patient Resources / Community

Patient resources on Pseudoxanthoma elasticum medical therapy

Discussion groups on Pseudoxanthoma elasticum medical therapy

Patient Handouts on Pseudoxanthoma elasticum medical therapy

Directions to Hospitals Treating Pseudoxanthoma elasticum medical therapy

Risk calculators and risk factors for Pseudoxanthoma elasticum medical therapy

Healthcare Provider Resources

Symptoms of Pseudoxanthoma elasticum medical therapy

Causes & Risk Factors for Pseudoxanthoma elasticum medical therapy

Diagnostic studies for Pseudoxanthoma elasticum medical therapy

Treatment of Pseudoxanthoma elasticum medical therapy

Continuing Medical Education (CME)

CME Programs on Pseudoxanthoma elasticum medical therapy

International

Pseudoxanthoma elasticum medical therapy en Espanol

Pseudoxanthoma elasticum medical therapy en Francais

Business

Pseudoxanthoma elasticum medical therapy in the Marketplace

Patents on Pseudoxanthoma elasticum medical therapy

Experimental / Informatics

List of terms related to Pseudoxanthoma elasticum medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Overview

Medical Therapy

Currently, there is no specific or effective treatment available for PXE.[1] The management focuses on prevention, screening, and management of complications.

Ocular complications

Treatment is indicated when choroidal neovascularisation (CNV) developes.

  • Laser photocoagulation - Photocoagulation using light (xenon) and argon has been used with discouraging results in the past. Research reveals that laser photocoagulation for macular CNV in association with angioid streaks is of limited application due to the high percentage of neovascular membrane relapse.[2]
  • Transpupillary thermotherapy (TTT) - This involves the delivery of heat through the dilated pupil into the posterior segment of the eye. This therapy may decrease the activity of CNV in the short term but retreatment may be necessary with unfavourable results.[3]
  • Photodynamic therapy - This involves the use of verteporfin for the treatment of CNV in the macular. This method has not been widely accepted due to its inability to improve the natural course of CNV in angioid streaks.[4]
  • Anti-VEGF therapy - Intravitreous injection of vascular endothelial growth factor antagonists such as Ranibizumab, Bevacizumab have been used with excellent results.
  • Vitamins A, C, E and zinc supplements may reduce the risk of bleeding.

Cardiovascular complications

  • Diet and exercise - These are the main methods to minimize the extent of cardiovascular disease. Exercises help in weight reduction and it stimulates collateral blood vessel development.
  • Pentoxifylline - This drug alters erythrocyte rheology, thus, reducing the blood viscosity. This drug should be used with caution due to its ability to cause hemorrhage.
  • Cessation of tobacco - Tobacco worsens the outcome of this condition.

References

  1. Uitto, J.; Váradi, A.; Bercovitch, L.; Terry, PF.; Terry, SF. (2013). "Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE international research meeting". J Invest Dermatol. 133 (6): 1444–9. doi:10.1038/jid.2013.20. PMID 23673496. Unknown parameter |month= ignored (help)
  2. Lim, JI.; Bressler, NM.; Marsh, MJ.; Bressler, SB. (1993). "Laser treatment of choroidal neovascularization in patients with angioid streaks". Am J Ophthalmol. 116 (4): 414–23. PMID 7692728. Unknown parameter |month= ignored (help)
  3. Ozdek, S.; Bozan, E.; Gürelik, G.; Hasanreisoglu, B. (2007). "Transpupillary thermotherapy for the treatment of choroidal neovascularization secondary to angioid streaks". Can J Ophthalmol. 42 (1): 95–100. doi:10.3129/can j ophthalmol.06-089 Check |doi= value (help). PMID 17361248. Unknown parameter |month= ignored (help)
  4. Sickenberg, M.; Schmidt-Erfurth, U.; Miller, JW.; Pournaras, CJ.; Zografos, L.; Piguet, B.; Donati, G.; Laqua, H.; Barbazetto, I. (2000). "A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes". Arch Ophthalmol. 118 (3): 327–36. PMID 10721954. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources